CWPS — Conwest Associates, LP — trades on the OTC Pink market with a market cap of roughly $16 million. It is a micro-cap limited partnership with no sector classification, no analyst coverage, and no publicly tracked short interest.
The price story this week is the most concrete data point available. The stock closed at $26.77 on April 27, up just over 6% on both a one-day and one-week basis. That puts the one-month gain at about 3%. With no volume data, no options market, and no borrow activity in any tracked lending pool, it is impossible to determine what drove the move or whether it reflects genuine liquidity or a single transaction.
The dividend record offers a small window into the partnership's history. Conwest paid quarterly cash distributions through at least mid-2022, with amounts ranging from $0.92 to $1.54 per unit. The last recorded payment was in July 2022 — nearly four years ago. Whether distributions have continued but gone unreported, or whether the partnership suspended them, is not discernible from available data.
No insider trades, earnings events, analyst ratings, or institutional filings appear in the ORTEX dataset for this name. The absence of short interest data is consistent with the stock's profile: a thinly traded OTC partnership unit with minimal institutional footprint and no active lending market.
The key thing to watch for CWPS is any public filing — a partnership report, a distribution announcement, or an SEC disclosure — that would explain the recent price move and clarify the current status of distributions.
See the live data behind this article on ORTEX.
Open CWPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
